MCLA-114

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameMCLA-114
Drug Alias NameMCLA-114
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionT cell surface glycoprotein CD3 modulators
TargetsT cell surface glycoprotein CD3
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerus Nv
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerus Nv
Active IndicationsN/A
Inactive IndicationsMultiple Myeloma

Other Information

ATC CodeN/A
Related LinksN/A